These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. The role of hepatic macrophages in liver metastasis. Keirsse J; Van Damme H; Geeraerts X; Beschin A; Raes G; Van Ginderachter JA Cell Immunol; 2018 Aug; 330():202-215. PubMed ID: 29661474 [TBL] [Abstract][Full Text] [Related]
7. Neutrophil: An emerging player in the occurrence and progression of metabolic associated fatty liver disease. Chen S; Guo H; Xie M; Zhou C; Zheng M Int Immunopharmacol; 2021 Aug; 97():107609. PubMed ID: 33887577 [TBL] [Abstract][Full Text] [Related]
8. The Multifaceted Roles of Macrophages in NAFLD Pathogenesis. Vonderlin J; Chavakis T; Sieweke M; Tacke F Cell Mol Gastroenterol Hepatol; 2023; 15(6):1311-1324. PubMed ID: 36907380 [TBL] [Abstract][Full Text] [Related]
9. Hepatic macrophages in liver homeostasis and diseases-diversity, plasticity and therapeutic opportunities. Wen Y; Lambrecht J; Ju C; Tacke F Cell Mol Immunol; 2021 Jan; 18(1):45-56. PubMed ID: 33041338 [TBL] [Abstract][Full Text] [Related]
10. Progression of non-alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat-cholesterol-sugar diet model in mice. Ganz M; Bukong TN; Csak T; Saha B; Park JK; Ambade A; Kodys K; Szabo G J Transl Med; 2015 Jun; 13():193. PubMed ID: 26077675 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases. van der Heide D; Weiskirchen R; Bansal R Front Immunol; 2019; 10():2852. PubMed ID: 31849997 [TBL] [Abstract][Full Text] [Related]
14. Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis. Li H; Zhou Y; Wang H; Zhang M; Qiu P; Zhang M; Zhang R; Zhao Q; Liu J Front Immunol; 2020; 11():1169. PubMed ID: 32670278 [TBL] [Abstract][Full Text] [Related]
15. Gemcabene downregulates inflammatory, lipid-altering and cell-signaling genes in the STAM™ model of NASH. Oniciu DC; Hashiguchi T; Shibazaki Y; Bisgaier CL PLoS One; 2018; 13(5):e0194568. PubMed ID: 29847555 [TBL] [Abstract][Full Text] [Related]
16. Macrophages as key regulators of liver health and disease. Papachristoforou E; Ramachandran P Int Rev Cell Mol Biol; 2022; 368():143-212. PubMed ID: 35636927 [TBL] [Abstract][Full Text] [Related]
17. Hepatic macrophages: Key players in the development and progression of liver fibrosis. Cheng D; Chai J; Wang H; Fu L; Peng S; Ni X Liver Int; 2021 Oct; 41(10):2279-2294. PubMed ID: 33966318 [TBL] [Abstract][Full Text] [Related]
18. Hepatocyte mitochondria-derived danger signals directly activate hepatic stellate cells and drive progression of liver fibrosis. An P; Wei LL; Zhao S; Sverdlov DY; Vaid KA; Miyamoto M; Kuramitsu K; Lai M; Popov YV Nat Commun; 2020 May; 11(1):2362. PubMed ID: 32398673 [TBL] [Abstract][Full Text] [Related]